A 52-Week, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosus
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Daniel WALLACE
Wallace Rheumatic Studies Center LLC
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
30 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Revmatologie S.R.O.
Brno, Czechia
- Revmatologický Ústav V Praze
Prague, Czechia
- Chu Felix Guyon
Saint-Denis, La Réunion, France
- Hopital Haut Lévêque
Bordeaux, France
- Hôpital Européen
Marseille, France
- Ghr Mulhouse Sud-Alsace
Mulhouse, France
- Hôpital Cochin
Paris, France
- Chu Strasbourg Hôpital de Hautepierre
Strasbourg, France
- Chu Strasbourg Nouvel Hôpital Civil
Strasbourg, France
- Schlosspark-Klinik Berlin
Berlin, Germany
- Clinic for Rheumatology and Internal Medicine
Freiburg im Breisgau, Germany
- Egyesitett Szt.István És Szt. László Kórház
Budapest, Hungary
- University of Debrecen Medical Center Department of Clinical Immunology
Debrecen, Hungary
- Synexus Gyula As
Gyula, Hungary
- Mentaház Magánorvosi Központ Kft.
Székesfehérvár, Hungary
- Cap Research
Phoenix, Mauritius
- Centrum Medyczne Plejady
Krakow, Poland
- Krakowskie Centrum Medyczne
Krakow, Poland
- Centrum Medyczne Hetmańska
Poznan, Poland
- Centrum Medyczne Oporow
Wroclaw, Poland
- Latin Clinical Trial Center
San Juan, PR, Puerto Rico
- Wallace
Los Angeles, California, United States
- East Bay Rheumatology Medical
San Leandro, California, United States
- Denver Arthritis Clinic
Denver, Colorado, United States
- Arthritis and Rheumatic Disease Specialties
Aventura, Florida, United States
- Mcilwain Medical Group
Tampa, Florida, United States
- Arthritis Research & Treatment Center
Stockbridge, Georgia, United States
- Innovative Health Research
Las Vegas, Nevada, United States
- Thurston Arthritis Research Center
Chapel Hill, North Carolina, United States
- Djl Clinical Research, Pllc
Charlotte, North Carolina, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2015
- Primary completion
- 31 Jan 2018
- Completion
- 31 Jan 2018
- Last update posted
- 11 Apr 2019
- Registered enrollment
- 202
- Registry id
- NCT02504645
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.